Laboratorio Reig Jofre SA (id:4739 RJF)
2.82 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/24/2024 10:05:48 PM)
Exchange closed, opens in 10 hours 54 minutes
About Laboratorio Reig Jofre SA
Market Capitalization 225.78M
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.
| Headquarters (address) |
Gran Capita, 10 Barcelona 08970 Spain |
| Phone | 34 93 480 67 10 |
| Website | https://www.reigjofre.com |
| Employees | 1,331 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | RJF |
| Exchange | Madrid Stock Exchange |
| Currency | EUR |
| 52 week range | 2.15 - 3.38 |
| Market Capitalization | 225.78M |
| Dividend yield forward | 5.67 % |
| Dividend yield forward Spain (ID:221, base:117) | 11.32 % |
| P/E trailing | 23.50 |
| P/E forward | 13.43 |
| Price/Sale | 0.677 |
| Price/Book | 1.06 |
| Beta | 0.887 |
| EPS | 0.120 |
| EPS Spain (ID:221, base:139) | 0.800 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Laboratorio Reig Jofre SA has raised their dividend 5.67 years in a row. This is below the 41490.207700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Laboratorio Reig Jofre SA has raised their dividend 27.06 years in a row. This is above the 24.025600 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Laboratorio Reig Jofre SA has raised their dividend 11.70 years in a row. This is below the 12.574800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Laboratorio Reig Jofre SA has raised their dividend 8.02 years in a row. This is below the 10.159600 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Laboratorio Reig Jofre SA has raised their dividend 33.70 years in a row. This is below the 147.852300 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Laboratorio Reig Jofre SA has raised their dividend 5.67 years in a row. This is below the 41490.207700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Laboratorio Reig Jofre SA has raised their dividend 27.06 years in a row. This is above the 24.025600 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Laboratorio Reig Jofre SA has raised their dividend 11.70 years in a row. This is below the 12.574800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Laboratorio Reig Jofre SA has raised their dividend 8.02 years in a row. This is below the 10.159600 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Laboratorio Reig Jofre SA has raised their dividend 33.70 years in a row. This is below the 147.852300 year average in the 'Drug Manufacturers Specialty & Generic' industry